missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Neurofibromin 1 Antibody (McNFn27a) - Azide and BSA Free, Novus Biologicals™
Mouse Monoclonal Antibody
Marque: Bio-Techne NBP2-80870
369.60 EUR valable jusqu'au 2025-03-28
Utilisez le code promo "25306" pour bénéficier de cette offre.
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
Neurofibromin 1 Monoclonal specifically detects Neurofibromin 1 in Human, Mouse, Rat, Guinea Pig samples. It is validated for Western Blot, ELISA, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry-Paraffin, Immunocytochemistry.
Spécification
Neurofibromin 1 | |
Monoclonal | |
1 mg/mL | |
Western Blot : 2-5 ug/ml, ELISA : 1:100-1:2000, Immunohistochemistry : 1:20 - 1:50, Immunoprecipitation : 1:10-1:500, Immunohistochemistry-Paraffin 1:20 - 1:50. Use reported in scientific literature, Immunocytochemistry | |
DKFZp686J1293, FLJ21220, Neurofibromatosis-related protein NF-1, neurofibromin, neurofibromin 1, NFNS, VRNF, WSS | |
Mouse | |
Protein A or G purified | |
RUO | |
Primary | |
Human and rodent. | |
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. | |
IgG1 κ |
Western Blot, ELISA, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry (Paraffin), Immunocytochemistry | |
McNFn27a | |
Unconjugated | |
PBS | |
NF1 | |
A highly conserved N-terminal peptide, corresponding to amino acids 27-41 of human Neurofibromin 1. [UniProt# P21359] | |
0.2 mL | |
Cancer, Cell Biology, Cell Cycle and Replication, Cellular Markers, Chromatin Research, Hypoxia, Neuroscience, Neurotransmission, Phospho Specific, Signal Transduction, Transcription Factors and Regulators, Tumor Suppressors | |
4763 | |
Human, Mouse, Rat, Guinea Pig | |
Purified |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Neurofibromin 1 Antibody (McNFn27a) - Azide and BSA Free, Novus Biologicals™ > 0.2 mL; Unconjugated
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu